相关实验视频
Updated: Sep 9, 2025

08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
3.4K
纳林因对内皮和心血管的影响:系统性审查
Jose A Adams1, Arkady Uryash1,2, Alfredo Mijares3
1Division of Neonatology, Mount Sinai Medical Center, Miami, FL 33140, USA.
Nutrients
|August 28, 2025
概括
通过改善内皮功能和保护免受缺血再输液损伤,类黄具有显著的心血管益处. 需要进一步对人体进行试验,以证实对心脏健康的最佳使用.
科学领域:
- 心血管研究
- 营养学科学
- 药理学
背景情况:
- 果中含有丰富的黄素, 已成为心血管健康的重要成分.
- 在过去的20年里,人们一直在探索其潜在的益处,特别是关于血管功能和心脏保护.
研究的目的:
- 系统地审查纳林因对内皮功能和心肌功能的影响.
- 评估纳林因对缺血再输血 (I/ R) 损伤的影响.
- 综合2000年至2025年间发表的细胞,动物和人类研究结果.
主要方法:
- 按照PRISMA 2020指南进行系统审查.
- 在PubMed,Scopus,EMBASE和Web of Science中进行全面的文献搜索.
- 包含62项研究 (细胞,动物,人类) 的偏差评估风险.
主要成果:
- 纳林的抗氧化,抗炎和血管保护作用是一致的.
- 机制包括PI3K/Akt,NF-κB,Nrf2,RAS通路的调节,以及细胞死亡通路的抑制.
- 动物研究显示血管松改善,心脏病发作大小减少;人体试验显示血脂状况和动脉硬度有所改善.
结论:
- 纳林因作为饮食补充剂具有显著的潜力,用于心血管保护,特别是对抗缺血性损伤.
- 它的血管保护和抗亡性质得到了机械学和临床前数据的支持.
- 进一步的临床试验至关重要,以确定最佳剂量并提高人类的生物可用性.
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
749
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
749
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Antihypertensive Drugs: Vasodilators
642
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
642
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
673
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
673

